IPO

Influx Healthtech Limited IPO

NSE SME

Listed On: Jun 25, 2025 at ₹ 132.5

₹ 230400 /2400 Shares
*Min Investment

Check Allotment

18 Jun, 2025

Open Date

20 Jun, 2025

Close Date

23 Jun, 2025

Allotment Date

25 Jun, 2025

Listing Date

OLD SME RULE

Influx Healthtech IPO Issue Details
  • Issue Price ₹91-96 per equity share
  • Face Value ₹10 Per Equity Share
  • Total Issue Size 61,00,800 shares(aggregating up to ₹58.56 crore)
  • Fresh Share 50,00,400 shares(aggregating up to ₹48 crore)
  • Offer For Sale 11,00,400 shares(aggregating up to ₹10.56 crore)
  • Listing at NSE SME
  • List Price 132.5
  • Listing Date 2025-06-25
  • Lead Manager Rarever Financial Advisors Pvt. Ltd
  • Registrar Maashitla Securities Private Limited
Market Lot Size

Investors can bid for a minimum of 1200 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

ApplicationLotsSharesAmount
Retail (min)11200₹1,15,200
Retail(max)11200₹1,15,200
NII (min) 22,400₹2,30,400
Influx Healthtech IPO Reservation

Influx Healthtech IPO offers total 32,64,000 shares. Out of which NA (18.97%) allocated to QIB, 4,65,600 (14.26%) allocated to NII,10,86,400 (33.28%) allocated to RII, NA (NA%) allocated to employees and NA (28.43%) allocated to Anchor investors.

Investor CategoryShares OfferedMaximum Allottees
Anchor Investor Shares OfferedNA (28.43%)
Market Maker Shares OfferedNA (5.05%)
QIB Shares OfferedNA (18.97%)
NII (HNI) Shares Offered4,65,600 (14.26%)
Retail Shares Offered10,86,400 (33.28%)
Total Shares Offered32,64,000 (100%)
Influx Healthtech IPO Documents
Influx Healthtech IPO Details


Influx Healthtech Limited IPO is an SME IPO, priced at ₹91-96 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform. The IPO comprises a total issue of 61,00,800 equity shares, aggregating up to ₹58.56 crores..

The IPO bidding window is open from Jun 18, 2025 to Jun 20, 2025. The allotment is expected to be finalized on Jun 23, 2025, and the tentative listing date is Jun 25, 2025.

The minimum lot size for Retail investors is 1200 shares, with a minimum investment of ₹1,15,200. For HNIs, the minimum application size is 2 lots , amounting to ₹ 2,30,400.

Rarever Financial Advisors Pvt. Ltd. is acting as the lead manager to the issue. The registrar of the IPO is Maashitla Securities Private Limited, and

Read More
Influx Healthtech IPO Subscription Analysis And Details
Retail
117.68x
Total
201.43x
As onQIB / NIIRetailTotal
Shares Offered / Reserved11,59,200 / 8,70,00020,29,20040,58,400
Day 1 18-06-25 06:00 PM
1.46 / 5.81 x8.46 x5.89 x
Day 2 19-06-25 06:00 PM
1.69 / 32.28 x36.13 x25.47 x
Day 3 20-06-25 06:00 PM
137.87 / 481.45 x117.68 x201.43 x

Total No of Applications
2,20,295
Influx Healthtech Valuations
EPS Pre IPO ₹7.36/-
EPS Post IPO ₹5.77/-
P/E Pre IPO 13.04
P/E Post IPO 16.63
ROE 36.98%
ROCE 49.17%
Debt/Equity 0.01
RoNW 36.98%
PAT Margin 12.75
Price to Book Value 7.62
Influx Healthtech Company Financials
In Crs.
In Cr.
31-Mar-2531-Mar-2331-Mar-22
Assets70.30N/AN/A
Revenue104.99N/AN/A
Profit After Tax13.37N/AN/A
Net Worth36.15N/AN/A
Reserves & Surplus18.00N/AN/A
Total Borrowing0.22N/AN/A
About Influx Healthtech Company

Incorporated in September 2020, Influx Healthtech Limited is a healthcare-centric company dealing in contract manufacturing. The company is a trusted CDMO offering specialized services to clients in various industries. The company has three manufacturing plants in Thane, Maharashtra, each with an area of 9,676 square feet, 13,000 square feet, and 14,000 square feet, respectively.

Product Portfolio:
Tablets, Capsules, and Powders
Liquid Orals and Softgels
Lozenges, Jellies, and Gummies
Oral Dispersible Films (ODFs)
Effervescent Tablets and Liquid-Fill Capsules
Candies and Gym/Sports Supplements
Skin Care and Body Care Products
Hair Care and Beard Care Solutions
Face Masks and Soaps.
Ayurvedic / Herbal formulations
Veterinary Feed Supplements
Homecare solutions

The Company assists Nutraceutical and Cosmetic companies with product development and manufacturing. It provides end-to-end solutions, from development to production and regulatory affairs, allowing customers to concentrate on formulation and commercialization.

As of June 11, 2025, there are 163 permanent employees on the payroll of the company.

Read More
Influx Healthtech - Promoter(s)

Mr. Munir Abdul Ganee Chandniwala

Mrs. Shirin Munir Ahmed Chandniwala

Mr. Abdul Ganee Abdul Rasul Chandniwala.

Pre Issue Share Holding : 99.85%

Post Issue Share Holding : 73.53%

Influx Healthtech IPO - Issue Objectives
1

Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division

2

Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division

3

Purchase of Machineries for Homecare and Cosmetic Division

4

General corporate purposes

Contact Details

Influx Healthtech

109, Ghanshyam Enclave Premises Co-op, Soc Plot No. 856, Laljipada, Kandivali West, Mumbai, Maharashtra 400067

91 7045997809

cs@influxhealthtech.com

https://influxhealthtech.com/

Registrar Contact Details

Maashitla Securities Private Limited

+91-11-45121795-96

Investor.ipo@maashitla.com

https://maashitla.com/allotment-status/public-issues